苑东生物(688513.SH)：参与全国药品集中采购拟中

Core Viewpoint - Yuan Dong Biotech (688513.SH) announced participation in the 11th national centralized drug procurement organized by the National Organization for Drug Procurement Office, with two products, namely, Dexmedetomidine Hydrochloride Injection and Beraprost Sodium Tablets, expected to be selected for this procurement [1] Group 1 - The company participated in the bidding for the 11th batch of national centralized drug procurement on October 27, 2025 [1] - The products involved in the procurement are Dexmedetomidine Hydrochloride Injection and Beraprost Sodium Tablets [1]